Top

Published in:

01-08-2012 | Literatur kommentiert

Organerhaltende Radiochemotherapie – eine geprüfte Alternative zur initialen Zystektomie bei Patienten mit muskelinvasivem Harnblasenkarzinom im Vergleich zur alleinigen Radiotherapie

Authors: PD Dr. C. Weiss, R. Sauer

Published in: Strahlentherapie und Onkologie | Issue 8/2012

Auszug

James ND, Hussain SA, Hall E et al (2012) Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer. N Engl J Med 366:1477–1488 …

(o A) (1996) Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research. Lancet 348:1049–1054

Dalbagni G, Genega E, Hashibe M et al (2001) Cystectomy for bladder cancer: a contemporary series. J Urol 165:1111–1116PubMedCrossRef

Efstathiou JA, Spiegel DY, Shipley WU et al (2012) Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience. Eur Urol 61(4):705–711PubMedCrossRef

Forastiere AA, Goepfert H, Maor M et al (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349:2091–2098PubMedCrossRef

Froehner M, Brausi MA, Herr HW et al (2009) Complications following radical cystectomy for bladder cancer in the elderly. Eur Urol 56:443–454PubMedCrossRef

Gore JL, Litwin MS, Lai J et al (2010) Use of radical cystectomy for patients with invasive bladder cancer. J Natl Cancer Inst 102:802–811PubMedCrossRef

Hautmann RE, Petriconi RC de, Pfeiffer C et al (2012) Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients. Eur Urol 61:1039–1047PubMedCrossRef

Hussain SA, Stocken DD, Peake DR et al (2004) Long-term results of a phase II study of synchronous chemoradiotherapy in advanced muscle invasive bladder cancer. Br J Cancer 90:2106–2111PubMed

James ND, Hussain SA, Hall E et al (2012) Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer. N Engl J Med 366:1477–1488PubMedCrossRef

10.

Krause FS, Walter B, Ott OJ et al (2011) 15-year survival rates after transurethral resection and radiochemotherapy or radiation in bladder cancer treatment. Anticancer Res 31:985–990PubMed

11.

Madersbacher S, Hochreiter W, Burkhard F et al (2003) Radical cystectomy for bladder cancer today – a homogeneous series without neoadjuvant therapy. J Clin Oncol 21:690–696PubMedCrossRef

12.

Rodel C, Grabenbauer GG, Kuhn R et al (2002) Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results. J Clin Oncol 20:3061–3071PubMedCrossRef

13.

Rodel C, Weiss C, Sauer R (2006) Trimodality treatment and selective organ preservation for bladder cancer. J Clin Oncol 24:5536–5544PubMedCrossRef

14.

Stein JP, Lieskovsky G, Cote R et al (2001) Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1054 patients. J Clin Oncol 19:666–675PubMed

15.

Tunio MA, Hashmi A, Qayyum A et al (2012) Whole-pelvis or bladder-only chemoradiation for lymph node-negative invasive bladder cancer: single-institution experience. Int J Radiat Oncol Biol Phys 82:e457–462PubMedCrossRef

Title: Organerhaltende Radiochemotherapie – eine geprüfte Alternative zur initialen Zystektomie bei Patienten mit muskelinvasivem Harnblasenkarzinom im Vergleich zur alleinigen Radiotherapie
Authors: PD Dr. C. Weiss
R. Sauer
Publication date: 01-08-2012
Publisher: Springer-Verlag
Published in: Strahlentherapie und Onkologie / Issue 8/2012
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI: https://doi.org/10.1007/s00066-012-0152-x

At a glance: The STEP trials

Springer Medicine

Organerhaltende Radiochemotherapie – eine geprüfte Alternative zur initialen Zystektomie bei Patienten mit muskelinvasivem Harnblasenkarzinom im Vergleich zur alleinigen Radiotherapie

Auszug

At a glance: The STEP trials

Springer Medicine

Auszug

Please log in to get access to this content

Other articles of this Issue 8/2012

Clinical relevance of different dose calculation strategies for mediastinal IMRT in Hodgkin’s disease

MRT-Mammographiescreening bei Patientinnen mit lobulärem Carcinoma in situ

Do patients with a limited number of brain metastases need whole-brain radiotherapy in addition to radiosurgery?

Acute mucosal radiation reactions in patients with head and neck cancer

Hyperfractionated accelerated radiotherapy with concomitant integrated boost of 70–75 Gy in 5 weeks for advanced head and neck cancer

Local progression and pseudo progression after single fraction or fractionated stereotactic radiotherapy for large brain metastases